Want to see TSE:JUSH full AI Analyst Report?
JUSH Stock Chart & Stats
C$0.77
>-C$0.01(-1.16%)
At close: 4:00 PM EST
C$0.77
>-C$0.01(-1.16%)
Day’s Range― - ―
52-Week RangeC$0.39 - C$1.33
Previous CloseN/A
Volume6.90K
Average Volume (3M)104.97K
Market Cap
C$137.79M
Enterprise ValueC$351.93M
Total Cash (Recent Filing)C$40.17M
Total Debt (Recent Filing)C$301.43M
Price to Earnings (P/E)―
Beta1.22
Next Earnings
Aug 06, 2026EPS Estimate
-0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.36
Shares Outstanding199,696,600
10 Day Avg. Volume128,959
30 Day Avg. Volume104,975
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)-1.07
Price to Sales (P/S)0.47
P/FCF Ratio285.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.21
Revenue Forecast (FY)C$270.52M
Bulls Say, Bears Say
Bulls Say
Margin ExpansionSustained gross margin improvement to ~45% indicates stronger product-level economics and mix. Durable margin expansion supports higher adjusted EBITDA and cash generation, providing a structural buffer against price competition and enabling reinvestment in operations and brand building.
Improving Cash GenerationConsistent positive operating and free cash flow signals improving underlying cash conversion from the business. Over a multi-month horizon this strengthens ability to fund maintenance/growth capex, service debt, and reduce reliance on dilutive financing, supporting financial durability.
Federal Rescheduling TailwindRescheduling to Schedule III is a structural regulatory change that could materially lower tax burdens (Section 280E) for medical sales, which were ~60% of 2025 revenue. That legal shift should sustainably improve after-tax margins and cash flow assuming implementation by Treasury/DEA.
Bears Say
Negative Equity And High LeverageA negative equity position combined with ~$300M of debt leaves the capital structure fragile. This reduces shock-absorption capacity, constrains strategic flexibility, heightens refinancing and covenant risk, and limits ability to pursue acquisitions or fund expansion without incremental financing.
Elevated Interest Burden From RefinancingThe new secured term loan increases recurring cash interest costs and adds refinancing risk when principal comes due. A high coupon and OID raise the company’s fixed financial obligations, reducing free cash available for growth and making profitability more sensitive to revenue volatility.
Modest Retail Growth & Pricing PressureRetail is the core revenue engine; persistent modest same-store growth and promotional-driven pricing pressure indicate competitive market dynamics. Over time this can compress retail margins, limit top-line scalability from new stores, and force higher marketing spend to defend share.
Jushi Holdings News
JUSH FAQ
What was Jushi Holdings’s price range in the past 12 months?
Jushi Holdings lowest stock price was C$0.39 and its highest was C$1.33 in the past 12 months.
What is Jushi Holdings’s market cap?
Jushi Holdings’s market cap is C$137.79M.
When is Jushi Holdings’s upcoming earnings report date?
Jushi Holdings’s upcoming earnings report date is Aug 06, 2026 which is in 37 days.
How were Jushi Holdings’s earnings last quarter?
Jushi Holdings released its earnings results on May 12, 2026. The company reported -C$0.142 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.142.
Is Jushi Holdings overvalued?
According to Wall Street analysts Jushi Holdings’s price is currently Overvalued.
Does Jushi Holdings pay dividends?
Jushi Holdings does not currently pay dividends.
What is Jushi Holdings’s EPS estimate?
Jushi Holdings’s EPS estimate is -0.07.
How many shares outstanding does Jushi Holdings have?
Jushi Holdings has 199,696,600 shares outstanding.
What happened to Jushi Holdings’s price movement after its last earnings report?
Jushi Holdings reported an EPS of -C$0.142 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.449%.
Which hedge fund is a major shareholder of Jushi Holdings?
Currently, no hedge funds are holding shares in TSE:JUSH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Jushi Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
40.27%
12-Months-Change
Fundamentals
Return on Equity
66.16%
Trailing 12-Months
Asset Growth
-2.70%
Trailing 12-Months
Company Description
Jushi Holdings
Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for the medical and adult-use markets in the United States. The company offers flowers, extracts, concentrates, edibles, pre-rolls, infused blunts, cannabis-infused gummies and chocolates, tinctures, capsules, softgels, and topical products, as well as vaporization devices and cartridges under the Hijinks, The Bank, The Lab, Tasteology, Uncommon Kind, Nira + Medicinals, and Sèche brands. It also engages in the sale of bulk raw materials to third parties. In addition, the company operates medical cannabis dispensaries under the Beyond Hello, Nature's Remedy, and NuLeaf brands. It markets its products to local dispensaries and large multi-state operators. Jushi Holdings Inc. was founded in 2018 and is headquartered in Boca Raton, Florida.
Technical Analysis
Options Prices
Currently, No data available
---